703 Results

American Association Of Clinical Endocrinologists And American College Of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care Of Patients With Obesity

Development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and the American College of Endocrinology...

Evidence-based indications for the use of PET-CT in the United Kingdom 2016

Since its introduction into clinical practice in the UK 26 years ago, positorn emission tomography (PET) followed by positron emission tomography-computed tomography...

Non-Hodgkin’s lymphoma: diagnosis and management: NICE Guidelines

This guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over.

NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

CLL remains the most prevalent adult lerkemia in Wester countries but is considered rare in regions such as East Asia. CLL/SLL comprises approximately 7% of newly diagnosed cases of NHL.

Multiple Myeloma: ESMO Clinical Practice Guidelines

The ESMO Clinical Practice Guideline in multiple myeloma, which accounts for approximately 10% of all haematological malignancies, covers recommendations for diagnosis; staging and risk assessment...

Hodgkin's Lymphoma: ESMO Clinical Practice Guidelines

The 2014 update elaborates on two histologically distinguished entities: classical Hodgkin's lymphoma that accounts about 95% of cases and nodular lymphocyte-predominant Hodgkin's lymphoma...

Myelodysplastic Syndromes: ESMO Clinical Practice Guidelines

Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders predominating in the elderly, with a median age at diagnosis of ~70 years.

Acute Lymphoblastic Leukaemia: ESMO Clinical Practice Guidelines

The estimated overall incidence of acute lymphoblastic leukaemia and lymphoblastic lymphoma in Europe is 1.28 per 1 000 000 individuals annually, with significant age-related variations

Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines

Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of non-Hodgkin’s lymphomas. Most DLBCLs originate in lymph nodes, but ≤40% initially present in extranodal sites.

Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clinical Practice Guidelines

Follicular lymphomas are the second most frequent subtype of nodal lymphoid malignancies in Western Europe. The annual incidence of this disease is rare but has increased during recent decades.

Load more